Wide Ranks

AVTR

Avantor, Inc.

21.04

Top Statistics
Market Cap 14 B Forward PE 18.38 Revenue Growth -0.30 %
Current Ratio 1.54 Trailing PE 46.76 Earnings Growth -50.00 %
Profit Margins 4.54 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 17.61 Enterprise / Revenue 2.78 Price To Sales Trailing12 Months 2.10
Profitability
Profit Margins 4.54 % Operating Margins 7.31 %
Balance Sheet
Total Cash 285 M Total Cash Per Share 0.4190 Total Debt 4 B
Total Debt To Equity 88.62 Current Ratio 1.54 Book Value Per Share 8.16
All Measures
Short Ratio 486.00 % Message Board Id finmb_403055588 Fax 610 573 2650
Shares Short Prior Month 33 M Return On Equity 0.0581 City Radnor
Uuid 04940212-8f2b-3c14-86b5-6c0c4142577d Previous Close 21.01 First Trade Date Epoch Utc 1 B
Book Value 8.16 Beta 1.35 Total Debt 4 B
Volume 5 M Price To Book 2.58 Fifty Two Week Low 19.59
Total Cash Per Share 0.4190 Total Revenue 6 B Shares Short Previous Month Date 1 B
Target Median Price 27.00 Audit Risk 4 Max Age 86400
Recommendation Mean 1.86 Sand P52 Week Change 0.3133 Operating Margins 7.31 %
Target Mean Price 27.31 Net Income To Common 309 M Ask 21.08
Short Percent Of Float 0.0470 Implied Shares Outstanding 699 M Last Fiscal Year End 1 B
Trailing Peg Ratio None Average Daily Volume10 Day 7 M Average Volume10days 7 M
Total Cash 285 M Next Fiscal Year End 1 B Revenue Per Share 10.05
Held Percent Insiders 0.0125 Ebitda Margins 15.78 % Trailing PE 46.76
Date Short Interest 1 B Most Recent Quarter 1 B Share Holder Rights Risk 1
Regular Market Previous Close 21.01 Target Low Price 24.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 23.53 Open 21.17 Free Cashflow 658 M
State PA Dividend Yield 0.00 % Return On Assets 0.0327
Time Zone Short Name EST Board Risk 3 Trailing Eps 0.4500
Day Low 21.00 Address1 Radnor Corporate Center Shares Outstanding 680 M
Compensation Risk 3 Price Hint 2 Target High Price 33.00
Website https://www.avantorsciences.com 52 Week Change -0.0066 Average Volume 5 M
Earnings Quarterly Growth -46.70 % Forward Eps 1.13 Recommendation Key buy
Compensation As Of Epoch Date 1 B Quick Ratio 84.20 % Is_sp_500 False
Regular Market Day High 21.38 Profit Margins 4.54 % Debt To Equity 88.62
Fifty Two Week High 28.00 Day High 21.38 Shares Short 31 M
Regular Market Open 21.17 Industry Key medical-instruments-supplies Bid 21.07
Earnings Growth -50.00 % Enterprise To Revenue 2.78 Revenue Growth -0.30 %
Shares Percent Shares Out 0.0469 Operating Cashflow 919 M Currency USD
Time Zone Full Name America/New_York Market Cap 14 B Is_nasdaq_100 False
Zip 19087 Quote Type EQUITY Industry Medical Instruments & Supplies
Long Name Avantor, Inc. Overall Risk 2 Regular Market Day Low 21.00
Held Percent Institutions 1.03 Current Price 21.04 Address2 Building One Suite 200 100 Matsonford Road
Enterprise To Ebitda 17.61 Financial Currency USD Current Ratio 1.54
Gross Margins 33.53 % Industry Disp Medical Instruments & Supplies Number Of Analyst Opinions 19
Country United States Float Shares 677 M Two Hundred Day Average 24.15
Governance Epoch Date 1 B Enterprise Value 18 B Price To Sales Trailing12 Months 2.10
Forward PE 18.38 Regular Market Volume 5 M Ebitda 1 B
Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies.

In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.

Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services.

The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.